GB1003802A
(en)
*
|
1963-06-04 |
1965-09-08 |
Searle & Co |
Pyrimidinone derivatives
|
GB1062357A
(en)
*
|
1965-03-23 |
1967-03-22 |
Pfizer & Co C |
Quinazolone derivatives
|
DE2027645A1
(de)
*
|
1970-06-05 |
1971-12-09 |
Byk Gulden Lomberg Chemische Fa bnk GmbH, 7750 Konstanz |
Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
|
US3900476A
(en)
*
|
1973-05-17 |
1975-08-19 |
Upjohn Co |
2(2'-pyrimidylamino)quinazolines and their preparation
|
US3936453A
(en)
*
|
1974-01-28 |
1976-02-03 |
Sandoz, Inc. |
1-Substituted-2-disubstituted aminoquin azolin-4(1h)-ones
|
US3959279A
(en)
*
|
1974-01-28 |
1976-05-25 |
Sandoz, Inc. |
1-Substituted-2-imino-quinazolin-4(1H)ones
|
US4113637A
(en)
*
|
1974-09-10 |
1978-09-12 |
Institut Francais Du Petrole |
Alkyl-guanidino-heterocyclic compounds, their manufacture and use as additives for fuels and lubricants
|
GB8429739D0
(en)
*
|
1984-11-24 |
1985-01-03 |
Fbc Ltd |
Fungicides
|
US5756502A
(en)
*
|
1994-08-08 |
1998-05-26 |
Warner-Lambert Company |
Quinazolinone derivatives as cholyecystokinin (CCK) ligands
|
WO1997010221A1
(fr)
*
|
1995-09-15 |
1997-03-20 |
Torrey Pines Institute For Molecular Studies |
Synthese de banques de quinazolinones
|
US6258819B1
(en)
*
|
1999-08-05 |
2001-07-10 |
Syntex (U.S.A.) Llc |
Substituted 2(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)-4(3H)-azaquinazolinones
|
US7230000B1
(en)
*
|
1999-10-27 |
2007-06-12 |
Cytokinetics, Incorporated |
Methods and compositions utilizing quinazolinones
|
US6545004B1
(en)
*
|
1999-10-27 |
2003-04-08 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
US7671200B2
(en)
*
|
1999-10-27 |
2010-03-02 |
Cytokinetics, Inc. |
Quinazolinone KSP inhibitors
|
US6667300B2
(en)
*
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
KR100785363B1
(ko)
*
|
2000-04-25 |
2007-12-18 |
이코스 코포레이션 |
인간 포스파티딜-이노시톨 3-키나제 델타의 억제제
|
EP1396488A1
(fr)
*
|
2001-05-23 |
2004-03-10 |
Mitsubishi Pharma Corporation |
Compose heterocyclique condense et son utilisation medicale
|
AU2002363429B2
(en)
*
|
2001-11-07 |
2008-05-08 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
WO2003043995A1
(fr)
*
|
2001-11-20 |
2003-05-30 |
Cytokinetics, Inc. |
Procede de racemisation de quinazolinones chirales
|
CA2475879A1
(fr)
*
|
2002-02-15 |
2003-08-28 |
Cytokinetics, Inc. |
Synthesis de quinazolinones
|
US7166595B2
(en)
*
|
2002-05-09 |
2007-01-23 |
Cytokinetics, Inc. |
Compounds, methods and compositions
|
US7214800B2
(en)
*
|
2002-05-09 |
2007-05-08 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
WO2003103575A2
(fr)
*
|
2002-05-23 |
2003-12-18 |
Cytokinetics, Inc. |
Composes, compositions et procedes
|
WO2003106426A1
(fr)
*
|
2002-06-14 |
2003-12-24 |
Cytokinetics, Inc. |
Composes, compositions et procedes
|
EP1537089A4
(fr)
*
|
2002-07-23 |
2008-04-16 |
Cytokinetics Inc |
Composes, compositions et procedes
|
US20040048853A1
(en)
*
|
2002-08-21 |
2004-03-11 |
Gustave Bergnes |
Compounds, compositions, and methods
|
WO2004034972A2
(fr)
*
|
2002-09-30 |
2004-04-29 |
Cytokinetics, Inc. |
Composes, compositions, et procedes
|
US7687625B2
(en)
*
|
2003-03-25 |
2010-03-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
CN1867560A
(zh)
*
|
2003-08-13 |
2006-11-22 |
武田药品工株式会社 |
4-嘧啶酮衍生物及其作为肽基肽酶抑制剂的用途
|
WO2005016348A1
(fr)
*
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Methodes d'inhibition de reponses immunes stimulees par un facteur endogene
|
US20050054614A1
(en)
*
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
JP2007505121A
(ja)
*
|
2003-09-08 |
2007-03-08 |
武田薬品工業株式会社 |
ジペプチジルぺプチダーゼ阻害剤
|
EP1697342A2
(fr)
*
|
2003-09-08 |
2006-09-06 |
Takeda Pharmaceutical Company Limited |
Inhibiteurs de dipeptidyle peptidase
|
EP1682534A2
(fr)
*
|
2003-11-03 |
2006-07-26 |
Cytokinetics, Inc. |
Derives de pyrimidin-4-one, compositions et methodes
|
EP1680420A4
(fr)
*
|
2003-11-07 |
2008-09-24 |
Cytokinetics Inc |
Composes, compositions et methodes
|
EP1692112A4
(fr)
*
|
2003-12-08 |
2008-09-24 |
Cytokinetics Inc |
Composes, compositions, et methodes associees
|
CN102079743B
(zh)
|
2004-03-15 |
2020-08-25 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
CA2566609C
(fr)
|
2004-05-13 |
2012-06-26 |
Icos Corporation |
Quinazolinones utilisees en tant qu'inhibiteurs de la phosphatidylinositol 3-kinase delta humaine
|
CA2567883A1
(fr)
*
|
2004-05-25 |
2005-12-15 |
Icos Corporation |
Methodes de traitement et/ou de prevention de la proliferation aberrante des cellules hematopoietiques
|
WO2006068978A2
(fr)
|
2004-12-21 |
2006-06-29 |
Takeda Pharmaceutial Company Limited |
Inhibiteurs de dipeptidyle peptidase
|
EP1885356A2
(fr)
*
|
2005-02-17 |
2008-02-13 |
Icos Corporation |
Inhibiteurs de la phosphoinositide 3-kinase pour inhiber l'accumulation des leucocytes
|
DE102005024017A1
(de)
*
|
2005-05-25 |
2006-11-30 |
Merck Patent Gmbh |
Chinazolinone
|
DK1942898T4
(da)
|
2005-09-14 |
2014-06-02 |
Takeda Pharmaceutical |
Dipeptidylpeptidase-inhibitorer til behandling af diabetes
|
US20070060529A1
(en)
*
|
2005-09-14 |
2007-03-15 |
Christopher Ronald J |
Administration of dipeptidyl peptidase inhibitors
|
KR101368988B1
(ko)
*
|
2005-09-16 |
2014-02-28 |
다케다 야쿠힌 고교 가부시키가이샤 |
디펩티딜 펩티다제 억제제
|
JP2009531456A
(ja)
*
|
2006-03-28 |
2009-09-03 |
武田薬品工業株式会社 |
(r)−3−アミノピペリジン二塩酸塩の調製
|
WO2007110868A2
(fr)
*
|
2006-03-28 |
2007-10-04 |
Atir Holding S.A. |
Composés hétérocycliques et leurs utilisations dans le traitement de troubles sexuels
|
AU2007296556B2
(en)
*
|
2006-09-13 |
2013-09-19 |
Takeda Pharmaceutical Company Limited |
Use of 2-6- (3-Amino-piperidin-1-yl) -3-methyl-2, 4-dioxo-3, 4-dihydro-2H-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile
|
US8324383B2
(en)
|
2006-09-13 |
2012-12-04 |
Takeda Pharmaceutical Company Limited |
Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
|
TW200838536A
(en)
*
|
2006-11-29 |
2008-10-01 |
Takeda Pharmaceutical |
Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
|
US8093236B2
(en)
|
2007-03-13 |
2012-01-10 |
Takeda Pharmaceuticals Company Limited |
Weekly administration of dipeptidyl peptidase inhibitors
|
NZ611764A
(en)
|
2008-11-13 |
2015-01-30 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
EA019499B1
(ru)
|
2009-03-24 |
2014-04-30 |
ГИЛИЭД КАЛИСТОГА ЭлЭлСи |
Производные атропоизомеров 2-пуринил-3-толилхиназолинона и способы применения
|
SG175259A1
(en)
*
|
2009-04-20 |
2011-11-28 |
Gilead Calistoga Llc |
Methods of treatment for solid tumors
|
WO2011011550A1
(fr)
|
2009-07-21 |
2011-01-27 |
Calistoga Pharmaceuticals Inc. |
Traitement de troubles du foie par des inhibiteurs de pi3k
|
US9353067B2
(en)
|
2011-04-10 |
2016-05-31 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
WO2013134288A1
(fr)
|
2012-03-05 |
2013-09-12 |
Gilead Calistoga Llc |
Formes polymorphes de l'acide -2-(1-(9h-purine-6-ylamino)propyl)-5-fluoro-3-phénylquinazolin-4(3h)-one
|
JP2017500319A
(ja)
|
2013-12-20 |
2017-01-05 |
ギリアード カリストガ エルエルシー |
(s)−2−(1−(9h−プリン−6−イルアミノ)プロピル)−5−フルオロ−3−フェニルキナゾリン−4(3h)−オンの塩酸塩の多形形態
|
JP2017502021A
(ja)
|
2013-12-20 |
2017-01-19 |
ギリアード カリストガ エルエルシー |
ホスファチジルイノシトール3−キナーゼ阻害剤のためのプロセス方法
|
CA2952012A1
(fr)
|
2014-06-13 |
2015-12-17 |
Gilead Sciences, Inc. |
Inhibiteurs de la phosphatidylinositol 3-kinase
|